202 related articles for article (PubMed ID: 11523316)
1. Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
Zacharieva S; Atanassova I; Natchev E; Orbetzova M; Tzingilev D
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):153-6. PubMed ID: 11523316
[TBL] [Abstract][Full Text] [Related]
2. Losartan in Cushing's syndrome.
Zacharieva S; Orbetzova M; Natchev E; Vergilova J; Andrewa M; Wipperrnann M; Torbova S; Tzingilev D; Angelova-Gateva P
Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):163-8. PubMed ID: 9604859
[TBL] [Abstract][Full Text] [Related]
3. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
[TBL] [Abstract][Full Text] [Related]
5. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
[TBL] [Abstract][Full Text] [Related]
6. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
7. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
Ponchon P; Elghozi JL
Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
[TBL] [Abstract][Full Text] [Related]
9. Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Int J Clin Pharmacol Ther; 2009 Aug; 47(8):525-32. PubMed ID: 19640361
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
[TBL] [Abstract][Full Text] [Related]
12. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R
Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
[TBL] [Abstract][Full Text] [Related]
13. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension.
Deng YB; Yang HY; Li CL; Chang Q
Clin Cardiol; 2002 Sep; 25(9):422-8. PubMed ID: 12269521
[TBL] [Abstract][Full Text] [Related]
17. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
Israili ZH
J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
[TBL] [Abstract][Full Text] [Related]
20. Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.
Deng YB; Wang DW; Li CL; Yang HY
Can J Cardiol; 2002 Apr; 18(4):389-96. PubMed ID: 11992132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
